These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22082280)

  • 1. Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids.
    Vasavda N; Woodley C; Allman M; Drašar E; Awogbade M; Howard J; Thein SL
    Br J Haematol; 2012 Apr; 157(2):249-52. PubMed ID: 22082280
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
    Darbari DS; Nouraie M; Taylor JG; Brugnara C; Castro O; Ballas SK
    Eur J Haematol; 2014 Apr; 92(4):341-5. PubMed ID: 24330217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.
    Mvalo T; Topazian H; Kamthunzi P; Chen J; Kambalame I; Mafunga P; Mumba N; Chiume-Chiphaliwali M; Paseli K; Key N; Gopal S; Hoffman I; Ataga K; Westmoreland K
    Blood Adv; 2018 Nov; 2(Suppl 1):30-32. PubMed ID: 30504195
    [No Abstract]   [Full Text] [Related]  

  • 4. Resolution of cerebral artery stenosis in a child with sickle cell anemia treated with hydroxyurea.
    Grace RF; Su H; Sena L; Poussaint TY; Heeney MM; Gutierrez A
    Am J Hematol; 2010 Feb; 85(2):135-7. PubMed ID: 20052745
    [No Abstract]   [Full Text] [Related]  

  • 5. Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide.
    Baird JH; Minniti CP; Lee JM; Tian X; Wu C; Jackson M; Alam S; Taylor JG; Kato GJ
    Br J Haematol; 2015 Mar; 168(5):737-46. PubMed ID: 25377027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure.
    Estepp JH; Wiczling P; Moen J; Kang G; Mack JM; Liem R; Panepinto JA; Garg U; Kearns G; Neville KA
    Br J Clin Pharmacol; 2018 Jul; 84(7):1478-1485. PubMed ID: 28884840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the role of hydroxyurea in children with sickle cell disease.
    Rogers ZR; Buchanan GR
    J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.
    Okam MM; Esrick EB; Mandell E; Campigotto F; Neuberg DS; Ebert BL
    Blood; 2015 Jun; 125(23):3668-9. PubMed ID: 26045597
    [No Abstract]   [Full Text] [Related]  

  • 9. The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease.
    Vasavda N; Badiger S; Rees D; Height S; Howard J; Thein SL
    Br J Haematol; 2008 Nov; 143(4):589-92. PubMed ID: 18764867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings.
    Inusa BPD; Wale A; Hassan AA; Idhate T; Dogara L; Ijei I; Qin Y; Anie K; Lawson JO; Hsu L
    F1000Res; 2018; 7():. PubMed ID: 30228870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea in sickle cell disease.
    Burke SM
    MCN Am J Matern Child Nurs; 1996; 21(4):210. PubMed ID: 8754440
    [No Abstract]   [Full Text] [Related]  

  • 12. Accidental hydroxyurea overdosage in a child with sickle cell anemia: An African experience.
    Nnebe-Agumadu U; Adebayo IA; Nnodu O; Adekile A
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28632. PubMed ID: 32743869
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxyurea treatment in children with sickle cell anemia in Central America and the Caribbean countries.
    Svarch E; Machín S; Nieves RM; Mancia de Reyes AG; Navarrete M; Rodríguez H
    Pediatr Blood Cancer; 2006 Jul; 47(1):111-2. PubMed ID: 16550531
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid and automated quantitation of dense red blood cells: A robust biomarker of hydroxyurea treatment response.
    Sadaf A; Quinn CT; Korpik JB; Pfeiffer A; Reynaud M; Niss O; Malik P; Ware RE; Kalfa TA; McGann PT
    Blood Cells Mol Dis; 2021 Sep; 90():102576. PubMed ID: 34020272
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea therapy in children severely affected with sickle cell disease.
    Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
    J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia.
    Bagdasaryan R; Glasser L; Quillen K; Chaves F; Xu D
    Lab Hematol; 2007; 13(3):93-7. PubMed ID: 17984040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea.
    Olnes M; Chi A; Haney C; May R; Minniti C; Taylor J; Kato GJ
    Am J Hematol; 2009 Aug; 84(8):530-32. PubMed ID: 19536844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and incidence of congenital anomalies amongst babies born to women with sickle cell disease and exposed to hydroxyurea during pregnancy: a systematic review protocol.
    Gwer SO; Onyango KO
    JBI Database System Rev Implement Rep; 2018 May; 16(5):1135-1140. PubMed ID: 29762306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.
    Tshilolo L; Tomlinson G; Williams TN; Santos B; Olupot-Olupot P; Lane A; Aygun B; Stuber SE; Latham TS; McGann PT; Ware RE;
    N Engl J Med; 2019 Jan; 380(2):121-131. PubMed ID: 30501550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.